Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C21H23NO5 |
| Molecular Weight | 369.411 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC=C2CC(=O)C3=CC4=C(OCO4)C=C3CCN(C)CC2=C1OC
InChI
InChIKey=HYBRYAPKQCZIAE-UHFFFAOYSA-N
InChI=1S/C21H23NO5/c1-22-7-6-14-9-19-20(27-12-26-19)10-15(14)17(23)8-13-4-5-18(24-2)21(25-3)16(13)11-22/h4-5,9-10H,6-8,11-12H2,1-3H3
| Molecular Formula | C21H23NO5 |
| Molecular Weight | 369.411 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Allocryptopine is isoquinoline alkaloid found primarily in the plant families Fumariaceae, Papaveraceae, Berberidaceae, Ranunculaceae, Rutaceae, and Sapindaceae. It have been reported to possess strong antibacterial, anti-inflammatoty, antiparasitic, antineoplastic and anti-addictive activities. Allocryptopine inhibits human acetylcholinesterase and butyrylcholinesterase. It blocks hERG current in HEK293 cells. Allocryptopine strongly enhanced the I(peak) of the T353I channel by enhancing the plasma membrane (PM) expression of Nav1.5 and rescued defective trafficking after co-incubation with HEK293 cells that carry mutation channel 24 h. A possible preparation for the treatment of HIV-1 and HIV-2 viruses containing pharmaceutically effective amounts of allocryptopine has been patented.
Originator
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL220 Sources: https://www.ncbi.nlm.nih.gov/pubmed/28708094 |
250.0 µM [IC50] | ||
Target ID: CHEMBL1914 Sources: https://www.ncbi.nlm.nih.gov/pubmed/28708094 |
530.0 µM [IC50] | ||
Target ID: Outward potassium current Sources: https://www.ncbi.nlm.nih.gov/pubmed/27403141 |
|||
Target ID: Slow delayed rectifier potassium current Sources: https://www.ncbi.nlm.nih.gov/pubmed/27403141 |
|||
Target ID: CHEMBL340 Sources: https://www.ncbi.nlm.nih.gov/pubmed/27054913 |
|||
Target ID: CHEMBL3397 Sources: https://www.ncbi.nlm.nih.gov/pubmed/27054913 |
|||
Target ID: CHEMBL3622 Sources: https://www.ncbi.nlm.nih.gov/pubmed/27054913 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | Unknown Approved UseUnknown |
|||
| Primary | Unknown Approved UseUnknown |
|||
| Curative | Unknown Approved UseUnknown |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Protopine and allocryptopine increase mRNA levels of cytochromes P450 1A in human hepatocytes and HepG2 cells independently of AhR. | 2011-06-10 |
|
| Phytochemical and antimicrobial characterization of Macleaya cordata herb. | 2010-12 |
|
| Acetylcholinesterase and butyrylcholinesterase inhibitory compounds from Chelidonium majus (Papaveraceae). | 2010-11 |
|
| Extractions of isoquinoline alkaloids with butanol and octanol. | 2010-09 |
|
| Optimization of microwave-assisted extraction of protopine and allocryptopine from stems of Macleaya cordata (Willd) R. Br. using response surface methodology. | 2010-07 |
|
| A study on separation and extraction of four main alkaloids in Macleaya cordata (Willd) R. Br. with strip dispersion hybrid liquid membrane. | 2010-07 |
|
| Metabolic diversification of benzylisoquinoline alkaloid biosynthesis through the introduction of a branch pathway in Eschscholzia californica. | 2010-06 |
|
| Electron ionisation mass spectral study of 2-(2-carboxy-4, 5-dimethoxyphenyl)-6,7-dimethoxyisoquinolinium inner salt. | 2009-11 |
|
| Isoquinoline alkaloids from Macleaya cordata active against plant microbial pathogens. | 2009-11 |
|
| [Alkaloids from Macleaya cordata]. | 2009-07 |
|
| Analysis of alkaloids in Macleaya cordata (Willd.) R. Br. using high-performance liquid chromatography with diode array detection and electrospray ionization mass spectrometry. | 2009-03-13 |
|
| Alkaloids from Mongolian species Hypecoum lactiflorum Kar. et Kir. Pazij. | 2009 |
|
| Alkaloids from Papaver nudicaule L. | 2008-05-10 |
|
| Effect of alpha-allocryptopine on transient outward potassium current in rabbit ventricular myocytes. | 2008 |
|
| Conventional sample enrichment strategies combined with high-performance liquid chromatography-solid phase extraction-nuclear magnetic resonance analysis allows analyte identification from a single minuscule Corydalis solida plant tuber. | 2007-09-07 |
|
| Analysis of Central European Corydalis species by nonaqueous capillary electrophoresis-electrospray ion trap mass spectrometry. | 2007-08-03 |
|
| Rapid determination of protopine, allocryptopine, sanguinarine and chelerythrine in fruits of Macleaya cordata by microwave-assisted solvent extraction and HPLC-ESI/MS. | 2006-12-06 |
|
| Proapoptotic activity of Ukrain is based on Chelidonium majus L. alkaloids and mediated via a mitochondrial death pathway. | 2006-01-17 |
|
| Iodination and radiolabeling of alpha-allocryptopine with iodine-125. | 2005-01 |
|
| Inhibition of mouse liver respiration by Chelidonium majus isoquinoline alkaloids. | 2003-12-15 |
|
| Antifungal activity of the methanolic extract and alkaloids of Glaucium oxylobum. | 2003-07 |
|
| Two new protopines argemexicaines A and B and the anti-HIV alkaloid 6-acetonyldihydrochelerythrine from formosan Argemone mexicana. | 2003-02 |
|
| Inhibitory effect of isoquinoline alkaloids on movement of second-stage larvae of Toxocara canis. | 2002-12 |
|
| Assay of nematocidal activity of isoquinoline alkaloids using third-stage larvae of Strongyloides ratti and S. venezuelensis. | 2002-03-01 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/15498685
Curator's Comment: To 1.0 ml of [125I] iodo-a-allocryptopine solution (about 300 mci) in ethanol was added 100 ml of Tween 80. The mixture was diluted to 10.0 ml with saline.
Mice: 0.15 ml of [125I] iodo-a-allocryptopine
Route of Administration:
Intravenous
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/25516845
The antiplasmodial assay on chloroquine-resistant strains of Plasmodium falciparum (PfK1) was conducted. The alkaloid allocryptopine presented IC50 value against P. falciparum of 1.46 ug/mL.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 20:04:24 GMT 2025
by
admin
on
Mon Mar 31 20:04:24 GMT 2025
|
| Record UNII |
EK27J8ROYB
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
m1527
Created by
admin on Mon Mar 31 20:04:24 GMT 2025 , Edited by admin on Mon Mar 31 20:04:24 GMT 2025
|
PRIMARY | Merck Index | ||
|
98570
Created by
admin on Mon Mar 31 20:04:24 GMT 2025 , Edited by admin on Mon Mar 31 20:04:24 GMT 2025
|
PRIMARY | |||
|
207-626-5
Created by
admin on Mon Mar 31 20:04:24 GMT 2025 , Edited by admin on Mon Mar 31 20:04:24 GMT 2025
|
PRIMARY | |||
|
485-91-6
Created by
admin on Mon Mar 31 20:04:24 GMT 2025 , Edited by admin on Mon Mar 31 20:04:24 GMT 2025
|
PRIMARY | |||
|
EK27J8ROYB
Created by
admin on Mon Mar 31 20:04:24 GMT 2025 , Edited by admin on Mon Mar 31 20:04:24 GMT 2025
|
PRIMARY | |||
|
Allocryptopine
Created by
admin on Mon Mar 31 20:04:24 GMT 2025 , Edited by admin on Mon Mar 31 20:04:24 GMT 2025
|
PRIMARY | |||
|
DTXSID60871677
Created by
admin on Mon Mar 31 20:04:24 GMT 2025 , Edited by admin on Mon Mar 31 20:04:24 GMT 2025
|
PRIMARY | |||
|
404531
Created by
admin on Mon Mar 31 20:04:24 GMT 2025 , Edited by admin on Mon Mar 31 20:04:24 GMT 2025
|
PRIMARY | |||
|
17390
Created by
admin on Mon Mar 31 20:04:24 GMT 2025 , Edited by admin on Mon Mar 31 20:04:24 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> CONSTITUENT ALWAYS PRESENT |